CAPTRUST FINANCIAL ADVISORS - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2023$206,950
+99.0%
3,346
+11.9%
0.00%0.0%
Q2 2022$104,000
+5.1%
2,990
+7.9%
0.00%0.0%
Q1 2022$99,000
+230.0%
2,770
+114.4%
0.00%
Q4 2021$30,000
+36.4%
1,292
+9.3%
0.00%
Q3 2021$22,000
-15.4%
1,182
-9.6%
0.00%
Q2 2021$26,000
-3.7%
1,307
-12.4%
0.00%
Q1 2021$27,000
+1250.0%
1,492
+1889.3%
0.00%
Q4 2020$2,000750.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders